glp-1 drugs and gallbladder receptor agonists disease risk: insights into molecular mechanisms and clinical implications GLP-1: Genetic Variants Related to
Description
Liraglutide reduces visceral and intrahepatic fat without significant loss of muscle mass in obese patients with type 2 diabetes: a prospective case series

A., Wookey, P
PMCID: PMC3942667

Diabetes Metabolism Research Reviews